Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Chong LMO"'
Autor:
Tobias J; Medical University of Vienna, Vienna, Austria., Maglakelidze M; ARENSIA Exploratory Medicine LLC, Tbilisi, Georgia., Andrić Z; Clinical Hospital Center Bezanijska Kosa, Belgrade, Serbia., Ryspayeva D; ARENSIA Exploratory Medicine LLC, Kyiv, Ukraine., Bulat I; ARENSIA Exploratory Medicine Research Unit, Institute of Oncology, Chisinau, Republic of Moldova., Nikolić I; Oncology Institute of Vojvodina, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia., Petrović Z; Military Medical Academy, Belgrade, Serbia., Chawla T; Tata Medical Centre, Kolkata, India., Nagarkar R; CG Manavata Cancer Centre, Nashik, India., Garner-Spitzer E; Medical University of Vienna, Vienna, Austria., Zielinski CC; Central European Cancer Center, Wiener Privatklinik, Central European Cooperative Oncology Group (CECOG), Vienna, Australia., Chong LMO; Imugene Limited, Sydney, Australia., Nixon B; Imugene Limited, Sydney, Australia., Ede NJ; Imugene Limited, Sydney, Australia., Yavrom S; Imugene Limited, Sydney, Australia., Kundi M; Medical University of Vienna, Vienna, Austria., Wiedermann U; Medical University of Vienna, Vienna, Austria.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Sep 13; Vol. 30 (18), pp. 4044-4054.
Autor:
Yuan Y; Cedars-Sinai Medical Center, 127 S San Vicente Blvd, Los Angeles, CA 90048, USA., Egelston C; Department of Immune-Oncology, City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, CA, USA., Colunga Flores O; Department of Immune-Oncology, City of Hope Comprehensive Cancer Center and Beckman Research Institute, Duarte, CA, USA., Chaurasiya S; Department of Surgery, City of Hope Comprehensive Cancer, Duarte, CA, USA., Lin D; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Chang H; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Chong LMO; Imugene Limited, Sydney, NSW, Australia., Seiz A; Imugene Limited, Sydney, NSW, Australia., Shah M; Imugene Limited, Sydney, NSW, Australia., Meisen WH; Department of Translational Development, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Tang A; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Martinez N; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Pickett W; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Murga M; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Yost SE; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Stewart D; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Zhang J; Department of Statistics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Ede N; Imugene Limited, Sydney, NSW, Australia., Modi B; Department of Surgery, City of Hope Comprehensive Cancer, Duarte, CA, USA., Kessler J; Department of Radiology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Rand J; Department of Surgery, City of Hope Comprehensive Cancer, Duarte, CA, USA., Fong Y; Department of Surgery, City of Hope Comprehensive Cancer, Duarte, CA, USA.
Publikováno v:
Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2023 Nov 10; Vol. 15, pp. 17588359231210675. Date of Electronic Publication: 2023 Nov 10 (Print Publication: 2023).